Posted in


SGLT-2 Inhibitors and other medications

Alternative medications may one day be used to treat new incidences of type 2 diabetes while also reducing the dependence on traditional ones. With more clinical investigations underway, the development of novel drugs aims to fill a needed gap in patient care.

Bridging Disciplines – Diabetes Faculty Profile

See the latest online issue of UF Explore magazine for an in-depth profile of Pat Concannon, PhD, director of the UF Genetics Institute. Concannon's research focuses on autoimmune diseases, particularly type 1 diabetes; pages 22-27.

A1C Champion: Running to Inspire Hope

Fellow UF Gator Alum Jonathan Wald proves that diabetes does not have to "run" your life. In spite of having no insulin production for many years, Jonathan has been able to maintain excellent control of his diabetes, and recently took part in the 21st Annual Walt Disney World Marathon. Check out his success story!

ADA Announces Diabetes Care Standards for 2014

The American Diabetes Association has issued its 'Standards of Medical Care in Diabetes' for 2014, which includes references to the research work of several UF Health diabetes research faculty. The standards emphasize an individualized approach to managing diabetes and discusses current criteria for diabetes diagnosis.

DEVOTE Study at UF Health

Are you 50 years or older and have established Type 2 diabetes and heart disease -- or risk factors for heart disease or chronic kidney disease? UF Health physicians are seeking participants for a new trial involving a once-daily new-generation insulin product.

Editorial on fructose features UF Health diabetes research study

A recent editorial piece published in the October edition of Nature Magazine cites the research work of one UF Health physician as growing concern for consumption of fructose, and the implications for development of liver disorders, cardiovascular disease, and type 2 diabetes.

UF Health Diabetes Faculty present at IDS 2013

Four distinguished UF Health diabetes experts will be heading 'Down Under' to Australia during the first week of December to highlight Type 1 diabetes (T1D) research work at the 13th International Congress of the Immunology Diabetes Society (IDS) in Lorne, Australia.

Metformin study seeks new T1D answers

UF Health diabetes researchers and patients will take part in a pilot study to determine whether metformin can improve blood sugar in patients with type 1 diabetes. JDRF and the Leona M. and Harry B. Helmsley Charitable Trust are funding the study and the DCE is one of only two Florida research centers participating.

November 14th is World Diabetes Day

World Diabetes Day, on November 14, is about mobilizing the global diabetes community to produce a powerful voice for diabetes awareness. Together, we can mobilize the campaign for diabetes awareness, and build on the effort to promote diabetes care, prevention and finding a cure worldwide.